Furthermore, “loss of ATRX in NF1 HGGs is unique when considered within the genetic contexts associated with ATRX mutations in sporadic gliomas,” in which they are typically associated with pediatric H3 K27M-mutant DMGs (24). The gene discussed is NF1; the disease is central nervous system cancer.